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 Heme-copper oxidases (HCOs) are large membrane proteins found in both 
bacteria and in eukaryotes. They catalyze about 90% of oxygen reduction in the 
atmosphere. They utilize a heme-copper center, which is comprised of a heme and a 
copper ion coordinated with three histidines, to catalyze the four-electron reduction of 
oxygen to water. Unfortunately, native enzymes are difficult to study because they are 
difficult to purify, and the presence of multiple metal cofactors make it difficult to 
characterize. Therefore, there is a need for small protein models that are able to mimic 
the native systems.  
Our lab was able to incorporate the heme-copper center found in HCOs in a 
smaller scaffold, Myoglobin, and the resulting mutant was named CuBMb. When our 
protein model was paired with its physiological electron transfer partner, cytochrome b5, 
fast electron transfer and O2 consumption was achieved, making our protein model 
system to have a catalytic rate similar to that of native HCOs.  
 A key to the above success was engineering the electrostatic interactions 
between CuBMb and cytochrome b5. As a result, the system works well only when the 
ionic strength of the buffer is <5 mM, which is outside the common physiological ionic 
strength. As a result, applications for this system are limited. To overcome this 
limitation, cytochrome b5 was engineered such that the interaction with myoglobin 
became hydrophobic, which allowed for a broader application scope. The mutants were 
designed using Rosetta, and their oxidase activity was characterized. However, after 
two rounds of Rosetta, the designed mutants had lower oxidase activity compared to 
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Chapter 1 Understanding Artificial Metalloproteins, Protein-Protein  
Interfaces, and Engineered Mb 
1.1 Artificial Metalloproteins 
Proteins are essential catalysts in important processes in living systems such as, 
photosynthesis and oxygen transport. These enzymes are known for their ability to have 
high turnover numbers, catalyze reactions quickly, operate under mild conditions, and 
have high selectivity and specificity.1 While nature is the best at doing chemistry, the 
reaction and substrate scope is limited to pathways in living systems. On the other 
hand, synthetic chemists have created a wide range of transition metal-based catalysis 
that can catalyze many reactions, including some that nature doesn’t do.2 Therefore, 
researchers have taken lessons from both nature and synthetic chemistry to create a 
new form of biocatalysis called artificial metalloproteins, which represents the benefits of 
nature and synthesis.  
The presence of a metal cofactor in a protein can serve many purposes including 
electron transport, directly interacting with and chemically modifying bound substrates, 
or being structural.3-6 While the metal cofactor is important in broadening the reactivity 
scope, the protein aspect should not be undermined. The protein environment 
surrounding the metal is key to determining function. A zinc based de novo 
metalloprotein has been used to stabilize a semiquinone radical that is an important 
intermediate in redox processes and catalysis.7 Upon generation of the radical, it will 
quickly coordinate with a zinc ion that is located in a hydrophobic pocket, which 
prevents it from being easily degraded in water.8 The combination of proteins and 
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metals produces a synergistic effect that allows scientists to go beyond chemistry that 
nature does.      
Modern molecular biology has made site directed mutagenesis an easy way to 
modify a protein’s design or activity. However, nature has limited us to 20 natural amino 
acids. Of these 20 amino acids, few are capable of coordinating to metal ions. To those 
interested in artificial metalloprotein design, choices are very limited. Biologists and 
chemists have found ways to expand the genetic toolbox to incorporate amino acids not 
found in nature. There are two main methods: synthetic and biological. 
The total synthesis of a protein can be achieved by solid-phase peptide synthesis 
(SPPS), where the C-terminal amino acid residue of the target protein sequence is 
covalently attached to an insoluble resin, and sequential amino acids residues are 
added by removing the protecting group from the amine. While this method allows for 
the complete control over the protein sequence, the longest chain possible is about 50 
amino acids long, due to the accumulation of impurities from incomplete reactions.9  
Within this category of total synthesis, is semi-synthesis where short peptides 
made using SPPS can be ligated to each other or ligated to a protein that has been 
expressed in common organisms, like E. coli. The two mechanisms that can accomplish 
this are native chemical ligation (NCL) and expressed protein ligation (EPL). Native 
chemical ligation involves the chemoselective reaction between the C-terminal thioester 
of one peptide and the N-terminal cysteine of another peptide that results in the 
formation of a peptide bond at the ligation site (Figure 1.1). Multiple peptide fragments 
were constructed using SPPS and ligated using NCL to generate a zinc finger variant 
(90 amino acids long), which allowed for the incorporation of a fluorophore and 
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unnatural amino acids to create an additional metal binding site.10 A major drawback of 
NCL is that it requires the addition of a thioester and cysteine that could lead to 
undesired disulfide bond formations.  
 
Figure 1.1 Mechanism of native chemical ligation11 
While NCL was an important discovery for the generation of proteins using 
peptide fragments, this method suffers greatly from time and money due to high cost of 
protected amino acids and ensuring the ligation is complete at each step. An 
improvement to NCL is EPL where the major peptide fragment is expressed in E. coli 
and is ligated to a short peptide that contains an unnatural amino acid or reactivity 
probe. The peptide fragment of the target protein is fused with an intein, a self-splicing 
protein domain, as well as an affinity tag, most commonly, a chitin binding domain.12 
The addition of an external thiol generates the necessary thioester needed for NCL 
(Figure 1.2). The N-terminal cysteine present on the short peptide fragment will then 
undergo NCL to the intein-bound protein and the resulting protein will be released upon 
completion. A pioneer example of EPL being used to modify metalloproteins was the 
replacement of the axial ligand methionine present in the type 1 copper site in 
Pseudomonas aeruginosa azurin (Az), a blue copper protein, with isostructural 
unnatural amino acid analogues. The replacement of these isostructural analogues 
allowed for the linear correlation between the hydrophobicity of the axial ligand and the 
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reduction potential of the copper ion.13 Furthermore, the replacement of the methionine 
with a strong ligand unnatural amino acid of similar size allowed for formation of a red 
copper protein from a blue copper protein.14  
 
Figure 1.2 Mechanism of expressed protein ligation15 
 While both NCL and EPL has allowed for atomic level precision in the creation of 
proteins, the ultimate tool for protein design would be for the entire protein, containing 
the unnatural amino acid, to be expressed in common organisms. Early discoveries of 
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this technology allowed for global substitution of the amino acid, however advances 
have been made to allow for site selectivity. This site selective approach involves the 
replacement of the codon encoding the amino acid of interest with a “blank” nonsense 
codon by oligonucleotide-directed mutagenesis.16 A tRNA synthase for the nonsense 
codon and desired unnatural amino acid is added in vitro, and the result is the unnatural 
amino acid inserted at the desired site. This method was used to incorporate 2-amino-3-
(4-hydroxy-3-(methylthio)phenyl)propanoic acid into a sperm whale myoglobin mimic of 
T. nitratireducens cytochrome c nitrite reductase, which aims to mimic the Tyr-Cys 
cofactor found natively, whose function is debated.17  
 The expansion of the genetic toolbox beyond the 20 natural amino acids has 
allowed protein engineers to incorporate new structural designs in different scaffolds 
that allow for new forms of catalysis or aim to mimic systems found in nature. Cofactors 
are the basis of catalysis, and usually contain a metal, which allows for its broad range 
of reactivity. Although there are catalytic cofactors present in nature that have been 
evolved to catalyze reactions with high yield, taking lessons from synthetic catalysts 
allows for the creation of new cofactors. Additionally, embedding these cofactors into 
protein scaffolds allows for higher regioselectivity and stereoselectivity.18 Therefore, by 
structurally tuning proteins, a new opportunity arises to incorporate non-native cofactors 
into scaffolds that don’t normally bind them.   
 There are four ways to incorporate a cofactor into a protein: covalent, 
supramolecular, dative, and metal substitution (Figure 1.3).19 Covalent attachment 
involves the formation of a covalent bond between a reactive group on the cofactor with 
a residue located in the protein pocket, which is contrasted by supramolecular 
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incorporation that relies on noncovalent interactions. Dative anchoring involves the 
coordination of a nucleophilic amino acid with an unsaturated amino acid and is used in 
conjunction with covalent or supramolecular attachment. Metal substitution relies on 
precisely tailored active sites, and substitutions for different metals that can lead to 
different functions.      
 
Figure 1.3 Summary of cofactor incorporation a) Covalent b) Supramolecular c) Dative d) Metal 
substitution19  
 
 These different methods of cofactor insertion allowed synthetic biologists and 
chemists to incorporate different moieties in protein scaffolds. Nitrobindin, a β-barrel 
protein scaffold has a large hydrophobic cavity suitable for the incorporation of a metal 
complex and hydrophobic organic compounds.20 This scaffold can be functionalized 
with an aromatic moiety that can promote stereospecific polycyclization and enolate 
addition reactions.21 When a pyrene moiety is covalently incorporated into the reaction 
cavity, it can catalyze an asymmetric Diels-Alder reaction between azachalcone and 
cyclopentadiene in the presence of CuII ions.20 While this particular scaffold could only 
catalyze this specific reaction, a protein scaffold could be made promiscuous in order to 
catalyze a wide range of reactions. A series of myoglobin mutants, which natively 
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contains a heme cofactor, has been developed to catalyze reactions including, N-H 
insertion, S-H insertion, and aldehyde olefination.22  
 The expansion of the genetic toolbox and the incorporation of non-native 
cofactors into metalloproteins has allowed for great discoveries being made in the field 
of biocatalysts. Scientists have been able to develop artificial metalloproteins for a wide 
range of functions, such as elucidating structural features from native systems using 
biosynthetic mimics, tuning redox potentials, and reaction catalysis.  
1.2 Protein-Protein Interactions  
 
 Nature uses metalloproteins with multiple active sites to perform a variety of 
biological functions, such in the case of cytochrome c oxidase which uses heme a to 
transfer electrons to the heme a3:CuB site for reduction of O2 to H2O.23 Although artificial 
metalloproteins with one catalytic site have been created, artificial metalloproteins with 
multiple sites are limited. These multiple sites can exist in many places, such as in one 
protein, in dimeric proteins, in de novo proteins, and in protein-protein interfaces.24 This 
section will mainly focus on protein-protein interfaces and interactions. 
 Communication is a crucial part to all organisms, whether it be humans, animals, 
or cells. Proteins communicate through physical interactions and require specificity. The 
ability to relay their messages to partners arises from biophysical interactions, such as 
hydrogen bonding, hydrophobicity, and electrostatics. The binding interface between 
two proteins usually represents a small region of the total protein, and the protein’s 
ability to find this surface with the correct confirmation is no easy task.  
 In solution, when two macromolecules collide, they will stay together for a certain 
period of time, and during this time, diffusional and rotational movements lead to 
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multiple microcollisions, allowing the macromolecule to sample a certain surface area of 
its partner.25 These collisions are non-specific and require no interaction forces between 
the macromolecules, due to the lifetime of the collision being insufficient for the 
molecules to find a small binding site on the partner.26 Simultaneously, a majority of 
macromolecule collisions do not result in a productive protein complex. There are two 
ways to increase the probability of forming a productive protein complex: increase the 
lifetime of the collision or influence the site of initial contact to reduce the surface area 
that needs to be searched.25 In both cases, electrostatic forces play an important role.  
 In the first scenario, the electrostatic forces between two macromolecules keeps 
them close together for a longer period, which allows for the molecules to search the 
surface of its partner through translational and rotational movements. The second 
scenario is mainly used to describe proteins with a charge dipole. For example, the 
binding between cytochrome c (Cc) and cytochrome c peroxidase (CcP) is limited by 
the orientation of their respective dipoles prior to approaching.25 However, in this case, 
both scenarios are used in a synergistic way. The second scenario will help to prolong 
the lifetime of the collision, while the charged areas can interact to find the correct 
orientation. The combination of these two factors greatly increases the probability of the 
proteins forming a productive complex, such that nearly all collisions yields the correct 
orientation. By understanding the mechanism in which how proteins interact with each 
other, we can potentially use this knowledge to develop new protein-protein interfaces 
or change the way that proteins interact with each other.  
 Protein-protein interactions have evolved in nature for their use in important 
biological pathways, such as photosynthesis. In photosynthesis, plastocyanin, a small 
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(~10 kDa) copper binding protein, plays a necessary role for photosynthetic growth in 
land plants by mediating the electron transfer between cytochrome b6f and photosystem 
I.27-28 Plastocyanin is negatively charged and interacts with the positive sites present on 
the cytochrome b6f complex and photosystem I. Despite the important role that 
plastocyanin plays, cytochrome c6, a protein of similar size, can replace its role without 
loss of function or activity.29-30 Despite plastocyanin and cytochrome c6 belonging to 
different classes of proteins, they can behave in similar ways towards the cytochrome 
b6f complex and photosystem I. Therefore, the ability for these small electron transport 
proteins to interact with multiple partners means that the mechanism which they do so is 
unspecific.  
 To make this interaction more general, researchers also must understand what 
other features are also at play. Although the binding of a protein to its partner is 
important, the dissociation step is also equally as important. The affinity (KD) of a protein 
complex is comprised of its association (kon) and dissociation (koff). The factors that 
influence association and dissociation are different. Association is dictated by diffusion 
and can be increased by electrostatic forces, as described above. Conversely, 
dissociation is governed by the strength between short range biophysical reactions, 
such as hydrogen bonding.31-33 Therefore, the factors that govern association and 
dissociation are different and require different strategies to improve.  
 To tune either association or dissociation, there must be pre-existing knowledge 
about the interactions between two proteins, as well as, a way to determine how 
mutations made would affect those interactions.34 However, this is not always possible 
because this method cannot be applicable for two proteins with an unknown interaction. 
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One possible way to overcome this challenge is to increase the interaction between two 
proteins that have been shown to interact, even if their interaction mechanism is 
unknown. By doing so, the rate of association will increase. In nature, superoxidase 
dismutaste (SOD) protects living cells from oxidative damage by converting a 
superoxide radical (O2•‾) to O2 and H2O2. This reaction occurs in its active site in the 
presence of copper, and its rate has been known to be enhanced by electrostatic 
interactions, but is diffusion limited.35-39 The crystal structure of human SOD shows that 
three important surface residues (E132, E133, and K136) form a hydrogen bonding 
network that is important for electrostatic guidance.37 Mutations were made to preserve 
this hydrogen bonding network, while increasing the local positive charge around the 
active site. The result of the analysis showed increased reaction rates and ionic-
strength dependence.40  
 By understanding the theory behind protein-protein interactions, this knowledge 
can be applied to a wide range of macromolecular interactions. As shown in the SOD 
example above, these methods can be used to further improve something nature has 
already evolved. At the same time, these mechanisms and parameters can be applied 
towards the development of new protein-protein interfaces, or for the creation of artificial 
protein partners for native substrates.  
1.3 The Myoglobin and Cytochrome b5 System  
   Heme-copper oxidases (HCOs) are large membrane proteins found both in 
bacteria and in eukaryotes and catalyze about 90% of oxygen reduction in the 
atmosphere.41-43 They are terminal enzymes in the respiratory electron-transport chain 
that utilizes a heme-copper center to catalyze the four-electron reduction of oxygen to 
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water.3 The study of these proteins will allow us to elucidate the structural features 
responsible for biological respiration and to gain insight for the development of catalysts 
for the oxygen reduction reaction (ORR) in fuel cells. While these proteins are important 
for biological function, studying them to elucidate features is not a trivial task. These 
proteins are large, membrane bound, and contain multiple metal centers, which makes 
it difficult to study a specific metal center. Therefore, a more favorable approach is to 
incorporate the non-heme binding site in HCO into a much smaller protein scaffold that 
natively does not have any additional metal centers.  The scaffold of choice for this non-
heme binding site is myoglobin (Mb) because it natively contains a high-spin heme iron 
coordinate by a histidine and binds oxygen with high affinity.44-46  
 In native HCOs, the heme-copper center uses three histidine residues to 
coordinate a copper, called CuB, in the distal heme pocket. Natively, myoglobin serves 
as a O2 transport protein, therefore to transform it into an oxidase, histidine residues 
should be introduced into the distal heme pocket. Native myoglobin already has a single 
histidine residue in the distal heme pocket. Therefore, with the help of structural 
overlays, two additional histidine residues were mutated into the distal heme pocket of 
myoglobin.47 The resulting mutant was named CuBMb.   
 In the active site of native HCOs, tyrosine plays an important role for function.3 
The introduction of tyrosine into CuBMb at two different positions close to the CuB site 
can reduce O2 to water with minimal release of reactive oxygen species. These 
mutants, F33Y-CuBMb and G65Y-CuBMb, are capable of high turnovers, but as slow 
oxidase activity.48 However, initial studies of these two mutants suggest that the rate 
limiting step is electron transfer into the catalytic center, which is consistent with studies 
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done on native cytochrome c oxidase.42 Therefore, in order to increase the rate of 
electron transfer, we paired our engineered myoglobin with its native redox partner 
cytochrome b5, which becomes reduced by NADH through NADH-cytochrome b5 
reductase.49 Hoffman and coworkers replaced three negatively charged amino acids 
(Asp44, Asp60, and Glu85) in myoglobin with positively charged lysine residues to 
increase the positive charge on Mb and improve the electrostatic interactions between 
the negatively charged cytochrome b5.50-51 Their work showed that this triple mutant 
called Mb(+6) was able to enhance the rate of ET from the triplet state of Zn-
deuteroporphyin-substituted Mb to ferric cytochrome b5 by two orders of magnitude.51  
Taking inspiration from their work, we incorporated the (+6) mutation into G65Y-CuBMb 
to create G65Y-CuBMb(+6). The addition of the three lysine mutations increased its 
oxidase activity to 52 s-1 from 0.30 s-1, which is comparable to the native enzyme.52  
  Despite our engineered myoglobin being capable of doing fast ORR, its 
applications are limited because of the electrostatic nature of the myoglobin: 
cytochrome b5 interface. Most experiments, whether in vitro or in vivo, are done in 
buffered solutions were the ionic strength is outside of the working range for this 
system. By changing the mechanism of their interaction, this system can potentially be 
used as an oxygen scavenger for single molecule fluorescence experiments, and co-
expression of these proteins in cells can allow for the aerobic expression of anaerobes. 
Therefore, in my work, I will redesign the interface between myoglobin and cytochrome 
b5 to make it amendable to high ionic strength, as well as study the dynamic range at 
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Chapter 2 Design and Activity of Cytochrome b5 and Myoglobin 
2.1 Introduction 
 There are computational methods available for a variety of applications, such as 
drug discovery and design, and protein design and characterization. Computational 
methods are used in conjunction with experimental methods to provide further insight 
that would normally be more expensive and labor intensive otherwise. The accuracy 
and quality of the predictions from these tools have become a standard for research.   
 Rosetta is a multi-component software package used for protein structure 
prediction and design and can be used without pre-existing experimental data. Rosetta 
utilizes a structure prediction algorithm that does two things. First, it explores or 
samples the conformational space or sequence space, then it accurately evaluates the 
energy of the resulting models. In order to do this, Rosetta uses a knowledge-guided 
Metropolis Monte Carlo sampling approach coupled with knowledge based energy 
functions that are based on molecular properties derived from information given from 
the Protein Data Bank (PDB).1     
 When sampling the conformational space, the program can set two types of 
constraints: backbone or side chain degrees of freedom. In both situations, one degree 
of freedom is held constant, while everything else can move.  While the Rosetta suite 
contains many sub-programs, the feature we are most interested in is its ability to 
design a protein-protein interface. This program combines refinement of rigid-body 
orientation and optimization of the amino acids at the interface to create new pairs of 
interacting site chains.2  
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 To redesign the interface, we needed to understand which face of the protein 
interacted with each other. While there was no crystal structure of the myoglobin and 
cytochrome b5 complex, the preferential face for interaction was determined by 
molecular docking. For our system, we used a web-based docking program, Patchdock, 
which is a geometry-based molecular docking algorithm that finds docking 
transformations that yield good molecular shape complementarity.3 This program is 
user-friendly because the input requires two PDBs of interest. After the docking was 
complete, the resulting complex structures were shown with their geometric score, 
desolvation energy, and interface area size. The top scoring structures had high 
geometric and interface area size scores, and low desolvation energies.4  
We have previously shown that fast electron transfer from cytochrome b5 to our 
engineered Mb quickly reduced O2 to water, and our goal was to use this system for 
other applications. In this work, I used these two programs to redesign the interface of 
cytochrome b5 and myoglobin by mutating residues on cytochrome b5, so that their 
interaction was dominantly hydrophobic instead of electrostatic. Additionally, the 
mutants resulting from Rosetta were expressed and purified, and their oxidase activity 
were measured under a variety of conditions.  
2.2 Materials and Methods 
Molecular dynamics: 
A molecular dynamics simulation was performed using NAMD and visual 
molecular dynamics (VMD) software.5 The structure was formed starting from the crystal 
structure of wild-type sperm whale myoglobin (PDB ID: 1VXA).6 A PSF file was 
generated using PSFGEN in the VMD software suite, and coordinates of missing atoms 
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and H atoms were predicted based on the topology of residues in the CHARMM force 
field.7 The MD simulation was performed using 10,000 steps of minimization followed by 
1,000,000 steps (2 ns) of equilibration.  
Patchdock and Rosetta design 
 Following the simulation of Mb(+6), an equilibration frame was chosen to be the 
starting PDB of Mb(+6) and was entered into Patchdock along with native cytochrome 
b5 (PDB ID: 1cyo).8 The resulting structures from Patchdock were analyzed, and the top 
10 docked structures were entered into Rosetta for the interface to be redesigned. The 
script for Rosetta included constraints dictating which residues could be mutated, as 
well as restrictions for certain parameters (Figure 2.1). Rosetta generated 1000 PDBs, 
along with the corresponding score files for every starting structure given. To get a 


































































 Mutations were incorporated into the native cytochrome b5 plasmid by Gibson 
assembly. The primers and G-blocks for 1st gen mutants were designed by Chang Cui 
in the lab.  
The 2nd gen mutants were created by using the following primers and G-blocks: 
Forward primer: 5'-CGA CCT GAC CAA ATT CC-3' 
Reverse primer: 5'-TCC AAA ACC TTT ATT ATC GG-3' 
Insert-403: 5’-CGA CCT GAC CAA ATT CCT AGA AGA ACA CCC TGG TGG CGA 
ACC GGA ACT CCT GGA AGG TGC AGG CGG TGA CGC GAC TCC GGG TTT CGA 
GGG TGT GGG CCA CTC TAC CGA TGC CCG TGA ACT GTC CAA AAC CTT TAT 
TAT CGG-3’ 
Insert-6184: 5’-CGA CCT GAC CAA ATT CCT AGA AGA ACA CCC TGG TGG CGA 
ATA TGT TCT CCT GGA ACA GGG TGG CAC CGA CGC GAC TCG TCC GTT CGA 
GCA GGT GGG CCA CTC TAC CGA TGC CCG TGA ACT GTC CAA AAC CTT TAT 
TAT CGG-3’ 
Insert-5771: 5’-CGA CCT GAC CAA ATT CCT AGA AGA ACA CCC TGG TGG CGA 
ACT GGT TCT CCA GGA ACA GGC AGG CGG TGA CGC GAC TAT TCC GTT CGA 
GGA TGT GGG CCA CTC TAC CGA TGC CCG TGA ACT GTC CAA AAC CTT TAT 
TAT CGG-3’ 
Insert-2853: 5’-CGA CCT GAC CAA ATT CCT AGA AGA ACA CGA AGG TGG CGA 
AGG TCC GCT CCG TGA ATT TGG TGG CAG CGA CGC GAC TCG TGG TTT CGA 





Protein expression and purification 
Mb(+6) 
Plasmid containing the Mb(+6) gene was transformed into BL21 (DE3) 
competent cells. Cultures of E. coli BL21 cells containing the expressed plasmid were 
grown in LB media for 6-8 hours at 37°C and used to inoculate 2 L flasks of 2xYT media 
containing 100 mg/L ampicillin. The cells were grown at 37°C for 12-16 hours with 
shaking at 200 rpm, and after a 4-hour induction with 50 mg/L isopropyl β-D-1-
thiogalactopyranoside (IPTG), they were harvested at 8000 x g.  
The harvested cell pellets were re-suspended in buffer A, containing 10 mM tris 
pH 7.2 (100 mL). The suspension was lysed using sonication, and the crude lysate was 
centrifuged at 12000 x g for three 15-min cycles. After each cycle, the solution was 
transferred to new tubes. The supernatant was incubated with CM Sepharose Fast Flow 
resin for 1 hour. The resin was washed with buffer A (300 mL), and protein was eluted 
with buffer B, containing 10 mM tris, 400 mM KCl, pH 7.2 (200 mL). The eluent was 
concentrated and loaded onto a size-exclusion column with Sephracryl S-200 resin for 
further purification. The identity and purity of the purified protein was verified by ESI 
mass spectrometry. (See supporting information)       
1st generation mutants 
Similar to Mb(+6), plasmid containing the protein gene was expressed into BL21 
(DE3) competent cells. E. coli BL21 cell cultures which contained the expressed 
plasmid were grown in LB media for 6-8 hours at 37°C and 2 L flasks of 2xYT media 
containing 100 mg/L ampicillin were then inoculated. Next, the cells were grown at 37°C 
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for 12-16 hours with shaking at 200 rpm, and following a 4-hour induction with 50 mg/L 
isopropyl β-D-1-thiogalactopyranoside (IPTG), they were harvested at 8000 x g.  
The harvested cell pellets were re-suspended in a lysis buffer containing 50 mM 
NaH2PO4, 300 mM NaCl, 10 mM imidazole pH 8 (100 mL). The suspension was lysed 
using sonication and the crude lysate was centrifuged at 12000 x g for three 15 min 
cycles. After each cycle, the solution was transferred to new tubes. The supernatant 
was incubated with Ni-NTA resin for 1 hour. The resin was washed with lysis buffer (25 
mL) and protein was eluted with elution buffer containing 50 mM NaH2PO4, 300 mM 
NaCl, 250 mM imidazole pH 8 (100 mL). The eluent was concentrated, and buffer 
exchanged to 100 mM potassium phosphate pH 7 using Sephadex G-25 resin. Heme 
was incorporated by adding 1.1 equivalents of 100 mM hemin based on the 280 nm 
absorption of the solution (ε = 4.470 mM-1cm-1) and allowed to stir for 30 minutes. The 
solution was loaded onto a size-exclusion column with Sephracryl S-200 resin for 
further purification. The identity and purity of the purified protein could not be verified by 
ESI mass spectrometry due to the stability of the protein. However, the right protein was 
expressed and purified because the plasmid had the correct sequence. (See supporting 
information)  
NADH-cytochrome b5 reductase, native cytochrome b5, and 2nd generation mutants  
The purification process also closely resembled the previous two times, except 
heme was incorporated endogenously, so no work up was needed after elution from the 
Ni-NTA resin. The eluent was concentrated and loaded onto a size-exclusion column 
with Sephracryl S-200 resin for further purification. The identity and purity of the purified 




 A UV-spectrum was taken of a mixture containing protein, NaOH, pyridine, and 
water. Solid dithionite was added, and a spectrum was taken until the absorbance peak 
at 557 nm no longer increased. The extinction coefficient of the protein was calculated 
by quantifying the amount of heme present by using the extinction coefficient for pyr2-
heme a. 
Oxidase activity 
 O2 consumption was measured by using an Oxygraph Clark-type oxygen 
electrode at 25°C in 5 or 100 mM potassium phosphate buffer, pH 7.0. Experiments 
were performed in duplicates to obtain a standard deviation. The electrode was 
calibrated against air-saturated buffer and O2 depleted buffer prior to use. Protein was 
buffer-exchanged to the respective buffer using Sephadex G-25 resin. The final 
concentrations of myoglobin, cytochrome b5, and cytochrome b5 reductase were 
adjusted to 50 nM, 5 μM, and 30.6 μM, respectively.  
2.3 Results and Discussion  
There was no PDB of Mb(+6), so the (+6) mutations were added to wild-type 
sperm whale myoglobin and simulated using molecular dynamics. A frame was chosen 
as the starting PDB to be added into Patchdock. The resulting structures from 
Patchdock were analyzed, and the heme edge distances were measured using VMD to 
ensure that the heme edge distances were less than 14 Å, the longest distance 
electrons can transfer without additional cofactors in between.9-10 The top 10 structures 
with heme edge distances less than 14 Å were used for Rosetta.  
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The output file for the resulting structures from Rosetta contained many 
parameters, but the ones of interest were: total score, sasa, sc, and buh. These 
represented solvent-accessible surface area of an interface, shape complementary, and 
buried unsatisfied hydrogen bonds. Therefore, structures of interest needed to have 
high total scores, sasa, and sc, and as few buried unsatisfied hydrogen bonds as 
possible.  
Initially, results were plotted by their sc and sasa scores (Figure 2.2). Following 
that, scores are filtered by setting the program to only show structures that met the 
following cut offs: sasa > 950, sc > 0.72, buh = 3 or 4, and total score < -500 (Figure 
2.3). The remaining structures were visualized by inspection, and five mutants were 
chosen to be expressed and purified.  
 





Figure 2.3 Remaining structures that meet the filter cutoffs   
Following the purification of the 1st gen mutants, their oxidase activity was 
measured (Figure 2.4). The mutants had low activity under both high and low salt 
conditions. However, mutants 5944, 7751, and 9282 retained activity under both ionic 
strength conditions. To possibly understand why their activity was so low, the output 
PDB from Rosetta was analyzed.  
 
 
Figure 2.4 Oxidase activity of 1st gen mutants. Conditions: 2 mM NADH, 50 nM Mb(+6), 5 μM cytochrome 




 Using Pymol, the mutations were highlighted in yellow by comparing the mutant 
sequence to the native sequence. As shown in Figure 2.5, the mutant PDBs were 
heavily mutated. Therefore, it was possible that the large number of mutations found on 
such a small protein perturbed its binding to cytochrome b5 reductase and Mb(+6), 
which resulted in low oxidase activity. The large number of mutations also indicated the 
proteins were unstable and unable to incorporate heme endogenously because heme 
had to be titrated in.  
 
Figure 2.5 1st gen mutant PDBs with mutations highlighted in yellow. a) 2541 b) 5944 c) 7751 d) 9282 
The next generation of mutants were designed in the same way, except that 
tighter constraints were implemented in Rosetta, which limited the number of residues 
the program could mutate. As a result, only residues at the protein-protein interface 
could be mutated and not anywhere else on cytochrome b5. The mutants that were 
expressed and purified were chosen in the same way as the 1st generation mutants.  
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Based on the purification, the 2nd gen mutants were more stable than 1st gen 
mutants because heme was incorporated endogenously, due to the cell pellets being 
highly colored. Following the purification of these mutants, their oxidase activity was 
measured (Figure 2.6). Unlike the 1st gen mutants where the activity stayed the same 
under different ionic strengths, nearly all the 2nd gen mutants displayed decreased 




Figure 2.6 Oxidase activity of 2nd gen mutants. Conditions: 2 mM NADH, 50 nM Mb(+6), 5 μM cytochrome 
b5, and 30.6 μM cytochrome b5 reductase  
 
 Although the 2nd gen mutants showed an improvement compared to the 1st gen 
mutants when based off their number of mutations and stability, the high ionic strength 
activity was very low. A possible explanation for this could be that the binding to 
cytochrome b5 reductase was disturbed. Or, that hydrophobicity was achieved, but the 
activity was very low relative to the native. In the next chapter, additional 
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Chapter 3 Characterization of Engineered Cytochrome 
b5/Myoglobin Interface 
3.1 Experimental Design  
 A possible explanation for the low activity under high ionic strength conditions of 
the 2nd gen mutants could be that the interaction between cytochrome b5 reductase and 
the cytochrome b5 mutants had been perturbed by the engineered interface. To 
investigate this, cytochrome b5 mutants became reduced by NADH reduced cytochrome 
b5 reductase, which can be observed by a change in the UV-Vis spectrum. If the 
interaction between the proteins is perturbed, no change should be observed in the 
spectrum.  
 Another possibility is that the interaction of the engineered interface was 
governed by hydrophobicity rather than electrostatics and this change caused the 
electron transfer to be inhibited, resulting in low oxidase activity. To determine whether 
the interaction is hydrophobic, the oxidase activity of the mutants was measured at 
different ionic strengths. If the interaction is hydrophobic, there should be no relationship 
between ionic strength and oxidase activity. In previous oxidase activity measurements, 
potassium phosphate was used as the buffer. However, a monoprotic buffer should be 
used to ensure that the ionic strength is exactly as measured. 
3.2 Materials and Methods 
Kinetics mode  
 A HP diode array spectrometer was used to take a UV-Vis spectrum every 0.5 
second over the span of 4 minutes and the absorbance at 413 nm was monitored. The 
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final concentrations of NADH, cytochrome b5, and cytochrome b5 reductase were 
adjusted to 500 nM, 7 μM, and 56 nM, respectively. 
Oxidase activity 
 O2 consumption was measured by using an Oxygraph Clark-type oxygen 
electrode at 25°C in 10 mM Tris-Cl, pH 7.0. Experiments were performed in duplicates 
to obtain a standard deviation. The electrode was calibrated against air-saturated buffer 
and O2 depleted buffer prior to use. Protein was buffer exchanged to 10 mM Tris-Cl, pH 
7.0 using Sephadex G-25 resin. The final concentrations of myoglobin, cytochrome b5, 
and cytochrome b5 reductase were adjusted to the following:   
Native: 100 nM, 10 μM, 160 nM 
5771: 250 nM, 25 μM, 400 nM 
403: 250 nM, 25 μM, 400 nM 
2853: 500 nM, 50 μM, 800 nM 
6184: 500 nM, 50 μM, 800 nM 
3.3 Results and Discussion  
 Native and mutant cytochrome b5 exhibited a Soret peak at 413 nm with visible 
peaks at 530 nm and 561 nm. Upon reduction with dithionite, the Soret shifted to 423 
nm and all peaks increased intensity (Figure 3.1). Ideally, 423 nm would be monitored; 
however, the extinction coefficient of the reduced species is unknown. Therefore, 413 
nm was monitored as we can relate the loss of the ferric cytochrome b5 to the formation 
of ferrous cytochrome b5. In Figure 3.2, all ferric forms of cytochrome b5 and mutants 
became reduced by NADH reduced cytochrome b5 reductase in a few seconds, except 
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for mutant 2853 in 100 mM KPi. However, this fivefold increase in the time it took for all 
molecules of cytochrome b5 to become reduced was insignificant. 
 
Figure 3.1 UV-vis spectra of ferric and ferrous forms of native and mutant cytochrome b5 
 
 
Figure 3.2 Kinetic curves from HP a) 5 mM KPi b) 100 mM KPi 
 
 If the electron transfer pathway to reduce oxygen to water is viewed as a series 
of individual steps, the following is observed:  
A. NADH + b5r
ox
k1














ox + Mb(+6)red 
D. Mb(+6)red + O2 + 4e
−
k4
→ H2O + Mb(+6)
ox 
In these experiments, step B was assumed to be rate limiting. Using the information 
obtained from the experiment, a theoretical oxidase activity for both native and mutant 
cytochrome b5 was calculated as followed:  
1. Calculate the slopes between each two sets of points. The smallest slope 
corresponds to where the rate of reduction is the fastest.  
2. Calculate the difference between the absorbances of the two points that gave rise to 
the rate.  
3. Use Beer’s law to calculate the concentration of cytochrome b5 by using the 
absorbance difference.  
4. Calculate the theoretical amount of Mb(+6) that would be used if this experiment was 
done on the Clark electrode. Cytochrome b5 is added in 100-fold excess compared 
to Mb(+6) 
5. Determine the rate at which ferric cytochrome b5 is converted to ferrous by taking the 
concentration is step 3 and dividing by the time between the two points. 
6. Divide Step 5 by the theoretical Mb(+6) concentration (Step 4). 
7. Divide by 4, as the conversion of water to oxygen is a four-electron process. This 
result is the theoretical oxidase activity.    
Using the above method, the theoretical oxidase activity was calculated to be 50 s-1 for 
native and mutant cytochrome b5 at both 5 and 100 mM KPi. The theoretical oxidase 
activity was much greater than the observed oxidase activity for the mutants, as shown 
in Chapter 2. This is evidence that step B was not the rate limiting step and therefore 
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made no difference whether it took 3 seconds or 30 seconds for all ferric forms of 
cytochrome b5 to be converted to ferrous cytochrome b5. Thus, the rate limiting step is 
step C, which is the reduction of Mb(+6) by reduced cytochrome b5. Furthermore, this 
semi-quantitative analysis provides evidence that the observed slow oxidase activity 
was not attributed to a perturbed interaction between cytochrome b5 reductase and the 
cytochrome b5 mutants. For a more quantitative analysis, stopped-flow experiments 
could be done to measure the value of k2. 
 In Chapter 2, the oxidase activity was only measured at 5 and 100 mM KPi. 
However, both in vitro and in vivo work were done at a wide range of ionic strengths. To 
understand the ionic strength dependence behavior, the oxidase activity was measured 
at a constant buffer capacity, but with varying ionic strength (Figure 3.3).  
 




All the mutants had lower oxidase activity than the native at a given salt concentration; 
however, there were differences in their salt sensitivities. The oxidase activity of mutant 
2853 dropped very little when increasing the ionic strength, while the decrease in 
activity was dramatic for native and other mutants.  
 Analysis of the docked structure of mutant 2853 with Mb(+6) showed 
phenylalanine (position 49) present at the interface (Figure 3.4). Natively, glutamine was 
present at that position and so was the case with mutants 6184 and 5771. The 
replacement of a charged amino acid (glutamine) with a hydrophobic residue 
(phenylalanine) helped to exclude water from the interface thus making it more 
hydrophobic and giving rise to the observed salt dependence trend.  
 
Figure 3.4 Mutant 2853 (red) docked with Mb(+6) gray. Interface mutations are shown in yellow  
 
 However, a different trend was observed in the case of mutant 403, where a 
glutamine to glycine mutation was present. The oxidase activity was much higher in 
mutant 403 than it was for mutant 2853 at any given ionic strength. Therefore, it is 
possible that changing glutamine to a small amino acid did not have an impact on the 
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amount of water present in the interface, like in mutant 2853. In both cases, it was 
impossible to know for certain unless a crystal structure was obtained.  
3.4 Future Directions 
 Much of the work described here is preliminary and further experiments are 
needed to achieve the goal of a fast electron transfer system capable of reducing 
oxygen to water under high ionic strengths. To investigate the presence of 
phenylalanine at position 49 for water exclusion, the mutation should be incorporated in 
native cytochrome b5 and the oxidase activity should be measured at different salt 
concentrations. Another key factor for the progression of this project is to obtain a 
crystal structure of native cytochrome b5 docked on Mb(+6).  
Furthermore, it is entirely possible that the approach of using Rosetta to redesign 
the interface between cytochrome b5 and Mb(+6) may not have been the best choice. 
After two rounds of Rosetta designs, the output yielded mutants that behaved worse 
than the native. Therefore, different approaches should be considered, such as linking 
the proteins together with a peptide linker to lower the kinetic barrier or finding a new 
electron transfer system that is better suited for this application.   
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Appendix A: Supporting Information 























ESI-MS of proteins  




































Mutant 2853 Expected: 12765 Observed: 12764 
 
